Quarterly ResultAug 7, 2026, 07:49 AM
Dentsply Sirona Q2 Net Sales $898M, GAAP EPS $0.18
AI Summary
Dentsply Sirona reported second quarter 2026 financial results, with net sales decreasing 4.1% to $898 million. The company achieved a GAAP diluted EPS of $0.18, a significant improvement from a loss of $0.22 in the prior year, while adjusted EPS remained flat at $0.52. Dentsply Sirona also announced an expanded partnership with Medline Sinclair and repurchased 1.3 million shares, while reiterating its full-year 2026 outlook for net sales and adjusted EPS.
Key Highlights
- Net sales decreased 4.1% to $898 million in Q2 2026.
- GAAP diluted EPS was $0.18, compared to ($0.22) in Q2 2025.
- Adjusted EPS remained flat at $0.52 in Q2 2026.
- GAAP gross margin improved to 54.9% from 52.4% year-over-year.
- Operating cash flow increased to $99 million from $48 million.
- Repurchased 1.3 million shares of common stock for $12 million.
- Reiterated 2026 net sales outlook of $3.5 billion to $3.6 billion.
- Expanded partnership with Medline Sinclair in Canada.
Price Impact
More from XRAY